The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

All agenciesFDA (Food)FDA (Drugs)FDA (Devices)USDA FSISCPSCNHTSAEPA

Category

All categoriesFoodDrugMedical DeviceVehicleConsumer Product

Minimum severity

Any3+ (High and above)4+ (High and above)5+ (High and above)

Clear filters

8801–8825 of 17974

  • SevereFDA (Drugs)·D-0355-2019·2019-01-16

    Lupin Recalls Ceftriaxone Injection Vials Due to Rubber Particulate Matter

    Lupin Pharmaceuticals is recalling Ceftriaxone for Injection USP, 250 mg, due to the presence of grey rubber particulate matter from stoppers in reconstituted vials.

    Product
    Ceftriaxone for Injection USP, 250 mg, packaged in a) one Single Use Vial (NDC 68180-611-01) and b) 10 Single Use Vials per box (NDC 68180-611-10); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland 21202; Manufactured by: Lupin
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0351-2019·2019-01-16

    Baxter Recalls Dianeal Low Calcium Dialysis Solution Due to Sterility Concerns

    Baxter Healthcare is recalling 29,370 bags of Dianeal Low Calcium peritoneal dialysis solution because confirmed customer complaints identified leaks in the tubing, compromising sterility.

    Product
    DIANEAL LOW CALCIUM WITH DEXTROSE — DIANEAL LOW CALCIUM WITH DEXTROSE (SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0387-2019·2019-01-16

    Allergan Recalls Ozurdex Dexamethasone Implants Due to Silicone Particulate

    Allergan is recalling 133,716 cartons of Ozurdex (dexamethasone) intravitreal implants because a silicone particulate was detected. The product was distributed to various accounts throughout the United States.

    Product
    OZURDEX — OZURDEX (DEXAMETHASONE)
    Category
    Drug
    Distribution
    1 state
  • HighFDA (Drugs)·D-0374-2019·2019-01-16

    PharMEDium Recalls Subpotent Buffered Lidocaine HCl Syringes Nationwide

    PharMEDium Services is voluntarily recalling 7,711 syringes of 0.9% Buffered Lidocaine HCl because the product was found to be subpotent.

    Product
    0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) 5 mL in 5 mL BD Syringe, 10 per carton Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land,
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-0375-2019·2019-01-16

    Lupin Recalls Cefdinir Oral Suspension Due to CGMP Deviations

    Lupin Pharmaceuticals is recalling Cefdinir for Oral Suspension because product complaints indicated the reconstituted suspension was observed to be thick.

    Product
    CEFDINIR — CEFDINIR (CEFDINIR)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0376-2019·2019-01-16

    Lupin Recalls Cefdinir Oral Suspension Due to CGMP Deviations

    Lupin Pharmaceuticals is recalling Cefdinir for Oral Suspension due to product complaints indicating the reconstituted suspension was observed to be thick.

    Product
    CEFDINIR — CEFDINIR (CEFDINIR)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0395-2019·2019-01-09

    Northwest Compounding Pharmacy Recalls HCG Liquid Due to Sterility Concerns

    Northwest Compounding Pharmacy is recalling HCG liquid vials because they may lack sterility assurance. The product was distributed in Oregon to medical facilities and patients.

    Product
    HCG liquid, 1000u/ml, RX, glass vial, various
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0404-2019·2019-01-09

    Northwest Compounding Pharmacy Recalls Cyclosporin Liquid Due to Sterility Concerns

    Northwest Compounding Pharmacy is recalling compounded Cyclosporin liquid 0.5% in plastic dropper bottles due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities, a physician's office, and patients.

    Product
    Cyclosporin liquid 0.5%, Rx, plastic dropper bottle
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0398-2019·2019-01-09

    Northwest Compounding Pharmacy Recalls Lidocaine/Epinephrine Liquid Due to Sterility Concerns

    Northwest Compounding Pharmacy is recalling Lidocaine/Epinephrine liquid 1%/1:1000 in 50 ml glass vials due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.

    Product
    Lidocaine/Epinepherine liquid 1%/ 1:1000, RX, glass vial These include injectable medications, sterile solutions, eye drops, and eye ointments
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0346-2019·2019-01-09

    Lupin Recalls Subpotent Nitrofurantoin Oral Suspension Lots

    Lupin Pharmaceuticals is recalling specific lots of Nitrofurantoin Oral Suspension because the drug was found to contain less active ingredient than required.

    Product
    NITROFURANTOIN — NITROFURANTOIN (NITROFURANTOIN)
    Category
    Drug
    Distribution
    Distributed nationwide